Among the candidate CpGDMs, we found eight genes with differential methylation previously associated with breast cancer susceptibility and pathology in the G2SBC and COSMIC Databases (AMOTL1, CDCP1, CYFIP1, MAP3K6, MIB2, SDK1, TAL1, and TYROBP) (Table S6). This evidence concerns the gene MIB2 and breast cancer.